GREENWICH BIOSCIENCES

EUIPO EUIPO 2016 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark GREENWICH BIOSCIENCES was filed as Word mark on 12/07/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/07/2017. The current status of the mark is "Trademark registered".

Trademark Details Last update: January 13, 2025

Trademark form Word mark
File reference 016140791
Application date December 7, 2016
Publication date December 29, 2016
Entry date April 7, 2017
Expiration date December 7, 2026

Trademark owner

Building 730 Kent Science Park
ME9 8AG Sittingbourne
GB

Trademark representatives

Harcourt Centre, Block 4 Harcourt Road D02 HW77 Dublin IE

goods and services

5 Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalised epilepsy with febrile seizures plus (GEFS positive), dup 15, and Doose syndrome; pharmaceutical preparations and substances for the treatment of bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, LennoxGastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis; pharmaceutical preparations and substances for the treatment of metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness; pharmaceutical preparations and substances for the treatment of diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalised epilepsy with febrile seizures plus (GEFS positive), dup 15, and Doose syndrome; medicinal infusions for treating bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis; medicinal infusions for treating metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness; medicinal infusions for treating diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes

Trademark history

Date Document number Area Entry
January 10, 2025 Transfer / Change of address, Published
October 14, 2021 Change Representative, Published
July 15, 2020 Transfer / Change of address, Published
December 13, 2019 Change Representative, Published
November 17, 2017 Change Representative, Published

ID: 11016140791